This is an HTML version of an attachment to the Freedom of Information request 'UAEM - Licensing and patenting practices of COVID-19 technologies - CLARIFIED'.


   
Business Assurance 
5th Floor 
 
Information Compliance 
James Clerk Maxwell Building 
 
57 Waterloo Road 
 
London 
SE1 8WA 
 
Tel:   020 7848 7816 
Email: xxxxxxxxxxxxxxx@xxx.xx.xx     
 
 
Sarai Keestra 
By email only to: xxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxxxxxx.xxx 
 
17 December 2020 
 
Dear Sarai Keestra 
 
Request for information under the Freedom of Information Act 2000 (“the Act”) 
 
Further to your recent request for information held by King’s College London, I am 
writing to confirm that the requested information is not held by the university. 
 
Your request 
 
We received your information request on 19 November 2020 and have treated it as 
a request for information made under section 1(1) of the Act. 
 
You requested the following information: 
 
START FOI request: 
 
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19 related 
health technologies? 
 
Q2. Does the institution have a formal policy on licensing and patenting of COVID-19 related 
technologies?  If yes, please provide a link or PDF to the relevant policy document. 
 
Q3. Has the university considered updating their strategy regarding the licensing and patenting of 
health technologies since the start of the pandemic? 
 
Q4. Please provide an Excel spreadsheet with headings as displayed below with all the COVID-19 
related health technologies LICENSED by the university AND specify which countries they were 
licensed in AND specify whether they are exclusive or non-exclusive licenses. 
 
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-
Exclusive 
 


  
Q5. Please provide a list of patents granted to your organization for any COVID-19 related health 
technologies listed by patent family, indicating countries/regions in which the patent has been 
granted. 
 
Q6. Does the institution have any plans on signing up to the Open-COVID pledge 
(https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopencovidpledge.org%
2F&data=04%7C01%7Cinfo-
compliance%40kcl.ac.uk%7C917dd5d348674567030c08d88c06230d%7C8370cf1416f34c16
b83c724071654356%7C0%7C0%7C637413305269433594%7CUnknown%7CTWFpbGZ
sb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0
%3D%7C1000&sdata=hP9sMZJnkaeTZb1Dm6J877a62KrxFkUqtnGCNR%2F86mc
%3D&reserved=0) or any similar initiative
 that seeks to minimise intellectual property 
rights barriers during the COVID-19 pandemic? If yes, please specify. 
 
Q7. Is the institution considering the licensing of COVID-19 related health technologies to the 
Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during the 
pandemic? If yes, please specify. 
 
 
Our response 
 
Q1. Can you release your internal strategy regarding licensing and patenting of COVID-19 
related health technologies?  
 
Information not held. 
 
 
Q2. Does the institution have a formal policy on licensing and patenting of COVID-19 
related technologies?  If yes, please provide a link or PDF to the relevant policy document. 
 
There is no specific formal policy on licensing and patenting of COVID-19 related 
technologies. The overarching policy (the Intellectual Property, Commercial Exploitation 
and Financial Benefit, Code of Practice) can be found here: 
 
https://www.kcl.ac.uk/governancezone/research/intellectual-property-commercial-
exploitation-and-financial-benefit 
 
 
Q3. Has the university considered updating their strategy regarding the licensing and 
patenting of health technologies since the start of the pandemic? 
 
No 
 
 
Q4. Please provide an Excel spreadsheet with headings as displayed below with all the 
COVID-19 related health technologies LICENSED by the university AND specify which 
countries they were licensed in AND specify whether they are exclusive or non-exclusive 
licenses. 
 

  
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-
Exclusive) 
 
As yet, KCL have not licensed any Covid related technologies. 
 
 
Q5. Please provide a list of patents granted to your organization for any COVID-19 related 
health technologies listed by patent family, indicating countries/regions in which the patent 
has been granted. 
 
Zero  
 
Q6. Does the institution have any plans on signing up to the Open-COVID pledge 
(https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fopencovidpledge.
org%2F&data=04%7C01%7Cinfo-
compliance%40kcl.ac.uk%7C917dd5d348674567030c08d88c06230d%7C8370cf1416f34c16
b83c724071654356%7C0%7C0%7C637413305269433594%7CUnknown%7CTWFpbGZsb
3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0
%3D%7C1000&sdata=hP9sMZJnkaeTZb1Dm6J877a62KrxFkUqtnGCNR%2F86mc
%3D&reserved=0) 
or any similar initiative that seeks to minimise intellectual property 
rights barriers during the COVID-19 pandemic? If yes, please specify. 
 
Review is ongoing. 
 
 
Q7. Is the institution considering the licensing of COVID-19 related health technologies to 
the Covid Technology Access Pool (C-TAP) or the Medicines Patent Pool (MPP) during 
the pandemic? If yes, please specify. 
 
No 
 
 
This completes the university’s response to your information request. 
 
Your right to complain 
 
If you are unhappy with the service you have received in relation to your 
information request or feel that it has not been properly handled you have the right 
to complain or request a review of our decision by contacting the Assistant Director 
of Business Assurance (Information Compliance) within 60 days of the date of this 
letter.  
 
Further information about our internal complaints procedure is available at the link 
below: 
 
http://www.kcl.ac.uk/college/policyzone/assets/files/governance_and_legal/Freed
om_of_Information_Policy_updated_Oct_%202011.pdf 
 
 
In the event that you are not content with the outcome of your complaint you may 
apply to the Information Commissioner for a decision. Generally, the Information 

  
Commissioner cannot make a decision unless you have exhausted the internal 
complaints procedure provided by King’s College London. 
 
The Information Commissioner can be contacted at the following address: 
 
The Information Commissioner’s Office 
Wycliffe House 
Water Lane 
Wilmslow 
Cheshire 
SK9 5AF 
 
 
Yours sincerely 
 
Olenka Cogias 
Information Compliance